P3-14-04: Assessment of Genomic Prognostic Signatures as Predictors of Response to Neoadjuvant Chemotherapy in Patients with Early Stage Breast Cancer.

Published

Journal Article

Full Text

Duke Authors

Cited Authors

  • Culakova, E; Poniewierski, MS; Huang, M; Kuderer, NM; Ginsburg, GS; Barry, W; Marcom, PK; Ready, N; Abernethy, A; Lyman, GH

Published Date

  • December 15, 2011

Published In

  • Poster Session Abstracts

Published By

Digital Object Identifier (DOI)

  • 10.1158/0008-5472.sabcs11-p3-14-04